ROIV

News Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts

12d ago

News Roivant gains after mid-stage trial data for Immunovant’s main asset

13d ago

SEC filing ROIV Reports $4.3B Cash, Reaches $2.25B Moderna Settlement

13d ago

News Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.

14d ago

News Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B

14d ago

News Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer

14d ago

News Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates

14d ago

News Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates

14d ago

News Quant snapshot: Baozun, Sohu among top-rated names as Sol Strategies, Arqit Quantum lag

16d ago

Short volume Short volume 84% of volume (5.7σ)

20d ago

Insider trade Sale by Matthew Gline (CEO)

39d ago

Insider trade Sale by Eric Venker (President & Immunovant CEO)

39d ago

Insider trade Sale by Eric Venker (President & Immunovant CEO)

40d ago

Insider trade Sale by Matthew Gline (CEO)

42d ago

Insider trade Sale by Jennifer Humes (Chief Accounting Officer)

52d ago

SEC filing ROIV Settlement Agreement with Moderna Resolves Patent Litigation, $50B Deal Size, 2026 Effective

71d ago

Insider trade Sale by Eric Venker (President & Immunovant CEO)

74d ago

Insider trade Sale by Melissa B, Epperly

75d ago

News Moderna gains as Arbutus/ Genevant settlement removes major financial risk

90d ago

News Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

90d ago

News Moderna surges after hours on patent settlement with Arbutus and Genevant

90d ago

News Pfizer-backed Priovant wins FDA priority review for lead asset

91d ago

Insider trade Sale by Frank Torti (President and Vant Chair)

95d ago

Insider trade Sale by QVT Financial LP

104d ago

Insider trade Sale by Daniel Allen Gold

104d ago